Bioventus
BVS
BVS
71 hedge funds and large institutions have $33.6M invested in Bioventus in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
52% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 27
56% less call options, than puts
Call options by funds: $7K | Put options by funds: $16K
59% less capital invested
Capital invested by funds: $81.8M → $33.6M (-$48.2M)
Holders
71
Holding in Top 10
2
Calls
$7K
Puts
$16K
Top Buyers
| 1 | +$2.15M | |
| 2 | +$1.06M | |
| 3 | +$298K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$165K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$162K |
Top Sellers
| 1 | -$3.59M | |
| 2 | -$1.47M | |
| 3 | -$1.4M | |
| 4 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$386K |
| 5 |
BlackRock
New York
|
-$285K |